Cargando…
Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer
Regulatory T (Treg) cells are potent suppressors that maintain immune homeostasis. Accumulation of Treg can inhibit effective immune responses in cancer patients, leading to tumor development and progression. Despite direct cytotoxicity, several chemotherapeutic drugs have been reported to deplete T...
Autores principales: | Li, Jie-Yao, Duan, Xiu-Fang, Wang, Li-Ping, Xu, Yu-Jie, Huang, Lan, Zhang, Teng-Fei, Liu, Jin-Yan, Li, Feng, Zhang, Zhen, Yue, Dong-Li, Wang, Fei, Zhang, Bin, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020463/ https://www.ncbi.nlm.nih.gov/pubmed/24868562 http://dx.doi.org/10.1155/2014/286170 |
Ejemplares similares
-
ANGPTL4 regulate glutamine metabolism and fatty acid oxidation in nonsmall cell lung cancer cells
por: Xiao, Song, et al.
Publicado: (2022) -
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
por: Hamai, Kosuke, et al.
Publicado: (2023) -
Therapeutic drug monitoring of docetaxel by pharmacokinetics and pharmacogenetics: A randomized clinical trial of AUC‐guided dosing in nonsmall cell lung cancer
por: Ma, Yuxiang, et al.
Publicado: (2021) -
Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
por: Ma, Li, et al.
Publicado: (2013) -
An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
por: Zhao, Nan, et al.
Publicado: (2015)